Access Vascular
Access Vascular is dedicated to transforming vascular access by developing innovative, biomaterial-based catheters that significantly reduce complications such as thrombosis, infections, and device failures. Founded with the mission to improve patient outcomes and reduce healthcare costs, the company offers a suite of products including HydroPICC® and HydroMID® that utilize its proprietary MIMIX® technology. With FDA clearances, a strong management team, and a commitment to quality, Access Vascular aims to lead the field in medical device innovation and improve vascular access procedures worldwide.
Industries
Nr. of Employees
small (1-50)
Access Vascular
40 Billerica Road, Billerica, MA 01821
Products
HydroPICC (single-lumen PICC)
Peripherally inserted central catheter constructed from a consistently hydrophilic biomaterial; intended to reduce thrombus accumulation and related complications compared with standard polyurethane catheters.
HydroPICC (dual-lumen PICC)
Dual-lumen peripherally inserted central catheter built from a hydrophilic biomaterial; intended to provide two-lumen access while reducing surface thrombus accumulation.
HydroMID (midline catheter)
Peripherally inserted midline catheter constructed from a consistently hydrophilic biomaterial; intended for short- to intermediate-term peripheral infusions with reported reductions in complication rates in retrospective data.
HydroPICC (single-lumen PICC)
Peripherally inserted central catheter constructed from a consistently hydrophilic biomaterial; intended to reduce thrombus accumulation and related complications compared with standard polyurethane catheters.
HydroPICC (dual-lumen PICC)
Dual-lumen peripherally inserted central catheter built from a hydrophilic biomaterial; intended to provide two-lumen access while reducing surface thrombus accumulation.
HydroMID (midline catheter)
Peripherally inserted midline catheter constructed from a consistently hydrophilic biomaterial; intended for short- to intermediate-term peripheral infusions with reported reductions in complication rates in retrospective data.
Services
Manufacture and distribution of PICC and midline catheters to hospitals and health systems through direct sales and distributor partnerships.
Provision of instructions for use, post-insertion care guidance, case studies and clinical summaries to support device adoption and clinician training.
Manufacture and distribution of PICC and midline catheters to hospitals and health systems through direct sales and distributor partnerships.
Provision of instructions for use, post-insertion care guidance, case studies and clinical summaries to support device adoption and clinician training.
Expertise Areas
- Medical device biomaterials
- Vascular access device design (PICC and midline)
- Preclinical and clinical data generation
- Analytical assays for microbial adhesion and thrombosis
Key Technologies
- Hydrophilic hydrogel biomaterials
- PICC and midline catheter design (single- and dual-lumen)
- In vitro bacterial adhesion assays
- In vitro and in vivo thrombus accumulation assays
News & Updates
Access Vascular announced new data demonstrating a dramatic reduction in complications with MIMIX technology and the HydroMID midline catheter.
The data demonstrates a significant reduction in complications with MIMIX technology and the HydroMID midline catheter.
New data from a device evaluation at Benefis hospital showing reduction in complications with MIMIX technology.
Partnership to submit HydroGUIDE™ technology for FDA clearance.
Preparing to submit HydroGUIDE™ technology for FDA clearance.
An overview of common complications associated with vascular access devices and potential solutions.
Access Vascular announced new data demonstrating a dramatic reduction in complications with MIMIX technology and the HydroMID midline catheter.
The data demonstrates a significant reduction in complications with MIMIX technology and the HydroMID midline catheter.
New data from a device evaluation at Benefis hospital showing reduction in complications with MIMIX technology.
Partnership to submit HydroGUIDE™ technology for FDA clearance.
Preparing to submit HydroGUIDE™ technology for FDA clearance.
An overview of common complications associated with vascular access devices and potential solutions.